Literature DB >> 316991

Lymphocyte changes in beta-thalassaemia major.

S Musumeci, G Schiliro, M A Romeo, A Sciotto, A Rosalba, G Pizzarelli.   

Abstract

Lymphocyte subpopulations were studied in 20 hypertransfused patients with beta-thalassaemia major, some of whom had been splenectomised. B-lymphocytes were normal but T-lymphocytes were decreased in all patients. The T-cell count was lower in the splenectomised patients than in the nonsplenectomised ones. In the former, the active rosette-forming lymphocytes were also diminished, but the difference was not significant. In all patients the percentage of null cells was greater and the activity of K-cells increased compared with controls.

Entities:  

Mesh:

Year:  1979        PMID: 316991      PMCID: PMC1545770          DOI: 10.1136/adc.54.12.954

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

Authors:  J T ELLIS; I SCHULMAN; C H SMITH
Journal:  Am J Pathol       Date:  1954 Mar-Apr       Impact factor: 4.307

2.  Cytotoxicity to isolated rabbit hepatocytes by lymphocytes from children with liver disease.

Authors:  A L Smith; A M Cochran; A P Mowat; A L Eddleston; R Williams
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

3.  Occurrence of circulating immune complexes in beta-thalassaemia major.

Authors:  P Casali; P Borzini; D Vergani; G Mieli-Vergani; G Masera; C Zanussi
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

4.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

5.  The "active" rosette test in immunodeficiency diseases.

Authors:  S Horowitz; T Groshong; R Albrecht; R Hong
Journal:  Clin Immunol Immunopathol       Date:  1975-09

6.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

7.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Effect of blood transfusion on the immune response of children with thalassaemia.

Authors:  F Kanakoudi-Tsakalidis; K Spyroglou; R Tzafi; C Cassimos
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

9.  Immunoglobulin spots on the surface of rabbit lymphocytes.

Authors:  B Pernis; L Forni; L Amante
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  4 in total

1.  Serum immunoglobulins, IgG subclasses, isohemagglutinins and complement-3 levels in patients with thalassemia major.

Authors:  C Vergin; N Kutukculer; N Cetingul; G Nisli; S Caglayan; S Oztop
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection.

Authors:  A Vierucci; M de Martino; M E Rossi; C Vullo; L Borgatti; W T London; B S Blumberg
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

3.  Immunological changes in beta-thalassemia major patients positive for HTLV-III antibodies.

Authors:  M A Romeo; G Russo Mancuso; L Mauro; A Sciotto; M A Romeo; F Di Gregorio; G Giammanco; G Schiliro
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

4.  Abnormalities in the immune system of children with beta-thalassaemia major.

Authors:  J Dwyer; C Wood; J McNamara; A Williams; W Andiman; L Rink; T O'Connor; H Pearson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.